Abstract
Immune haemolytic anaemia (IHA) is a recognised complication after allogeneic stem cell transplantation (SCT) and occurs more frequently if marrow cells have been subjected to T cell depletion (TCD). Among 58 consecutive patients who underwent TCD-allogeneic SCT from volunteer unrelated donors for the treatment of CML at the Hammersmith Hospital during a 3-year period (1 March 1996 to 28 February 1999) we identified nine cases of IHA. All patients had a strongly positive direct and indirect antiglobulin test and in eight patients the serological findings were typical of warm-type haemolysis often with antibody specificities within the Rh system. All nine cases had clinically significant haemolysis and were treated initially with prednisolone and immunoglobulin. The onset of IHA coincided with the occurrence of leukaemic relapse in six cases, and the presence of host haemopoiesis confirmed by lineage-specific chimerism in all four cases studied. Five patients received donor lymphocyte infusions (DLI); in three molecular remission and the restoration of full donor chimerism coincided with resolution of haemolysis. We conclude that in the context of leukaemic relapse, DLI is an effective therapy for IHA following allografts involving TCD. Bone Marrow Transplantation (2001) 28, 581–586.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hows J, Beddow K, Gordon-Smith E . Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation Blood 1986 67: 177–181
Klumpp TR . Immunohaematologic complications of bone marrow transplantation Bone Marrow Transplant 1991 8: 159–170
Klumpp TR, Caligiuri MA, Rabinowe SN et al. Autoimmune pancytopenia following allogeneic bone marrow transplantation Bone Marrow Transplant 1990 6: 445–447
De Lord C, Marsh JCW, Smith JG et al. Fatal autoimmune pancytopenia following bone marrow transplantation foraplastic anaemia Bone Marrow Transplant 1996 18: 237–239
Bashey A, Owen I, Lucas GF . Late onset immune pancytopenia following bone marrow transplantation Br J Haematol 1991 78: 268–274
Chen FE, Owen I, Savage D et al. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant Bone Marrow Transplant 1997 19: 491–495
Drobyski WR, Potluri J, Sauer D, Gottschall JL . Autoimmune hemolytic anemia following T cell-depleted allogeneic allogeneic bone marrow transplantation Bone Marrow Transplant 1996 17: 1093–1099
Drobyski W, Ash R, Casper J . Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment, relapse and disease-free survival in unrelated marrow transplantation for chronic myelogenous leukaemia Blood 1994 83: 1980–1987
Spencer A, Szydlo RM, Brookes PA et al. Bone marrow transplantation for chronic myeloid leukaemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: major prognostic impact of HLA Class I identity between donor and recipient Blood 1995 86: 3590–3597
Spencer A, Brookes PA, Kaminski E et al. Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors Transplantation 1995 59: 1302–1308
Sehn LH, Aleya EP, Canning C et al. Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion J Clin Oncol 1999 17: 561–568
Kolb HJ, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients Blood 1995 86: 2041–2050
Lawler M, Humphries P, McCann SR . Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction Blood 1991 77: 2504–2514
Mackinnon S, Barnett L, Heller G, O'Reilly RJ . Minimal residual disease is more common in patients who have mixed T cell chimerism after bone marrow transplantation for chronic myelogenous leukaemia Blood 1994 83: 3409–3416
Roux E, Abdi K, Speiser D et al. Characterization of mixed chimerism in patients with chronic myeloid leukemia transplanted with T-cell depleted bone marrow: involvement of different hematological lineages before and after relapse Blood 1993 81: 243–248
Serrano J, Roman J, Sanchez J et al. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210BCR-ABL and p190BCR-ABL after allogeneic bone marrow transplantation for chronic myeloidleukemia: increasing mixed myeloid chimerism and p190BCR-ABL detection precede cytogenetic relapse Blood 2000 95: 2659–2665
Lin F, van Rhee F, Goldman JM, Cross NCP . Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukaemia patients who relapse after bone marrow transplantation Blood 1996 87: 4473–4478
Gardiner N, Lawler M, O'Riordan JM et al. Monitoring of lineage-specific chimerism allows early prediction of response following donor lymphocyte infusions for relapsed chronic myeloid leukaemia Bone Marrow Transplant 1998 21: 711–719
Gardiner N, McCann SR, O'Riordan J, Lawler M . Chimerism following donor lymphocyte infusion for chronic myeloid leukemia Blood 1999 93: 2748–2749
Craddock C, Szydlo RM, Dazzi F et al. CMV serostatus is a major determinant of outcome after T depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored GVHD prophylaxis Br J Haematol 2001 112: 228–236
Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors Transplantation 1974 18: 295–304
Shulman HM, Sullivan KM, Weiden PL . Chronic graft-versus-host syndrome in man: a long-term clinicopathological study of 20 Seattle patients Am J Med 1980 69: 204–217
Cross N, Lin F, Chase A . Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukaemia after bone marrow transplantation Blood 1993 82: 1929–1936
Hochhaus A, Lin F, Reiter A et al. Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction Blood 1996 87: 1549–1555
Dacie JV, Lewis SME . Practical Haematology Churchill Livingstone: London 1995
Dazzi F, Szydlo RM, Craddock C et al. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia Blood 2000 95: 67–71
Moller G . Models of autoimmunity Immunol Rev 1990 118: 1–310
Mason D, Powrie F . Control of immune pathology by regulatory T cells Curr Opin Immunol 1998 10: 649–655
Dumont-Girard F, Roux E, van Lier RA et al. Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants Blood 1998 92: 4464–4471
Mackall CM, Fleischer T, Brown M et al. Age, thymopoiesis and CD4+ T lymphocyte regeneration following chemotherapy New Engl J Med 1995 332: 143–149
Douek DC, McFarland RD, Keiser PH et al. Changes in thymic function with age and during the treatment of HIV infection Nature 1998 396: 690–695
Wu CJ, Chillemi A, Alyea EP et al. Reconstitution of the T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism Blood 2000 95: 352–359
Hale G, Zhang M, Bunjes D et al. Improving the outcome of bone marrow transplantation by using CD52 monoclonal antibodies to prevent graft-versus-host disease and graft rejection Blood 1998 92: 4581–4590
Dazzi F, Szydlo RM, Cross NCP et al. Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia Blood 2000 96: 2712–2716
Claret EJ, Alyea EP, Orsini E et al. Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion J Clin Invest 1997 100: 855–866
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cwynarski, K., Goulding, R., Pocock, C. et al. Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusions. Bone Marrow Transplant 28, 581–586 (2001). https://doi.org/10.1038/sj.bmt.1703206
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703206
Keywords
This article is cited by
-
Immune-mediated cytopenias (IMCs) after HSCT for pediatric non-malignant disorders: epidemiology, risk factors, pathogenesis, and treatment
European Journal of Pediatrics (2023)
-
Autoimmune cytopenias after umbilical cord blood transplantation in adults with hematological malignancies: a single-center experience
Bone Marrow Transplantation (2014)
-
Successful donor-lymphocyte infusion for extreme immune-hemolysis following unrelated BMT in a patient with X-linked chronic granulomatous disease and McLeod phenotype
Bone Marrow Transplantation (2008)
-
Diagnosis and treatment of autoimmune haemolytic anaemias in adults: a clinical review
Wiener klinische Wochenschrift (2008)
-
Cold agglutinin disease associated with adenovirus infection after allogeneic bone marrow transplantation
Bone Marrow Transplantation (2005)